Aug 29, 2017
NEW YORK (360Dx) – VolitionRx reported a second quarter net loss of $3.5 million, or $.13 per share, compared to a net loss of $2.9 million, or $.13 per share, a year ago. The company said it had $16.5 million in cash and cash equivalents on June 30.
Read More
Aug 29, 2017
A study showing how rapid negative exclusion of blood cultures by a molecular method, Cognitor® Minus, can aid antimicrobial stewardship. UK study in general blood culture of 246 patients with suspected sepsis. In 74% of cases where Cognitor® Minus gave a negative result there was a positive antimicrobial stewardship outcome:
Read More
Aug 16, 2017
Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract manufacturing services, has raised £1.6M in its latest funding round. The new funding –supported by current investor Foresight VCTs and members of the senior management team – will allow the company to take its ReadyPlex™ rapid blood group genotyping assays into clinical trials and commercialisation, as well as invest in additional resources in its contract manufacturing infrastructure.
Read More
Aug 10, 2017
The latest addition to the SpeciSafe® range, from Alpha Laboratories, is a pack to enclose two paediatric blood or serum tubes. This extends the existing 1, 3, 6 and 10 serum vial packs. The dual serum tube pack also includes two stands to secure tubes for opening on the bench. In addition this versatile design can accommodate a single 1.2ml Monovette tube.
Read More
Jul 17, 2017
Cardiff, UK – 17th July 2017 – EKF Diagnostics, the global in vitro diagnostics company, has published a guide to ‘Diabetes and HbA1c testing’ which can be found at EKF’s new Diabetes Portal (www.ekfdiagnostics.com/diabetes-portal.html).
Read More
Jun 30, 2017
DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its nucleic acid extraction platform. The new platform will be used in combination with the DiaSorin Liaison® MDX PCR system to provide the customer with a complete sample to result system for molecular diagnostics.
Read More
Jun 26, 2017
Investment will help commercialize Cytox’s services for testing for Alzheimer’s disease and grow Cytox as a leader in this area. 15 June 2017, Oxford & Alderley Park, UK. Cytox, an emerging precision medicine leader providing genetic testing for Alzheimer’s disease, has announced that it has raised £2.6m (approx $3.3m) to fund the commercial launch and international roll out of its comprehensive testing service.
Read More
Jun 21, 2017
Cardiff, UK – 21st June 2017 – EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab-based HPLC system for the measurement of glycated hemoglobin (HbA1c).
Read More
Jun 21, 2017
The TOPRA Annual Symposium is the largest forum for European regulatory professionals to meet up, discuss current regulatory issues and debate future plans for regulation.
Read More
Jun 09, 2017
SYDNEY, AUSTRALIA -- 05/06/17 -- SpeeDx Pty, Ltd. today announced an agreement with Cepheid for distribution of its PlexPCRTM and ResistancePlusTM molecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the UK, will increase coverage for the market-leading ResistancePlus MG test, the first CE-IVD test for Mycoplasma genitalium to combine detection with testing for azithromycin resistance.
Read More
Page 8 of 10 [8]